Repsol S.A. (REP)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 28.26 |
|---|---|
| 52-week range | 14.54 – 31.64 |
| Return, 1 month / 3 months | −5.2% / +10.9% |
| Return, 1 year / 3 years | +101.9% / +131.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 33.6% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 82.37M EUR |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Repsol is an integrated energy company based in Madrid, Spain. It explores for and produces crude oil and natural gas, refines crude into fuels and other petroleum products, and sells petrol, diesel and lubricants through service stations under its own brand. The company also makes petrochemical products and supplies fuels and other energy products to industrial and retail customers, and it has expanded into low-carbon energy such as renewable power and biofuels.
The shares are listed on the Madrid Exchange in Spain under the code REP, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Repsol S.A. (REP) trades on the Madrid Exchange in Spain. It last closed at EUR 28.26 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 11 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 101.9% and over the last three months it rose 10.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.5% | ||
| From 52-week high | -10.4% | ||
| Momentum | 97 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.9% | ||
| 6-month return | 36.5% | ||
| 12-month return, skipping the last month | 113.0% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 82.37M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.7% |
|---|---|
| 1 month | −5.2% |
| 3 months | +10.9% |
| 6 months | +36.5% |
| 1 year | +101.9% |
| 3 years | +131.8% |
| 5 years | +233.0% |
Signals
| 50-day / 200-day average | 28.81 / 23.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2026 | EUR 0.5510 |
| 12 Jan 2026 | EUR 0.5000 |
| 4 Jul 2025 | EUR 0.5000 |
| 10 Jan 2025 | EUR 0.4750 |
| 4 Jul 2024 | EUR 0.5000 |
| 9 Jan 2024 | EUR 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.